The DOI matches its Crossref record; 72 of the 72 references it cites were found in a registry or an index.
Regulation of Phosphorylation of Thr-308 of Akt, Cell Proliferation, and Survival by the B55α Regulatory Subunit Targeting of the Protein Phosphatase 2A Holoenzyme to Akt
Open accessAbstract
Akt is a protein serine/threonine kinase that is involved in the regulation of diverse cellular processes. Phosphorylation of Akt at regulatory residues Thr-308 and Ser-473 leads to its full activation. The protein phosphatase 2A (PP2A) has long been known to negatively regulate Akt activity. The PP2A holoenzyme consists of the structural subunit (A), catalytic subunit (C), and a variable regulatory subunit (B). Here we report the identification of the specific B regulatory subunit that targets the PP2A holoenzyme to Akt. We found endogenous association of PP2A AB55C holoenzymes with Akt by co-immunoprecipitation analyses in pro-lymphoid FL5.12 cells. Akt was shown to associate with ectopically expressed B55alpha subunit in NIH3T3 cells. The direct interaction between B55alpha subunit and Akt was confirmed using in vitro pulldown analyses. Intriguingly, we found that overexpression of B55alpha subunit significantly impaired phosphorylation at Thr-308, but to a lesser extent at Ser-473 of Akt in both FL5.12 and NIH3T3 cells. Concomitantly, phosphorylation of a subset of Akt substrates, including FoxO3a, was substantially decreased by B55alpha overexpression in these cells. Silencing of B55alpha expression markedly increased phosphorylation at Thr-308 but not at Ser-473 in both FL5.12 cells and NIH3T3 cells. Consistently, PP2A AB55alphaC holoenzymes preferentially dephosphorylated phospho-Thr-308 rather than phospho-Ser-473 in in vitro dephosphorylation assays. Furthermore, B55alpha overexpression retarded proliferation of NIH3T3 cells, and knockdown of B55alpha expression increased survival of FL5.12 cells upon interleukin-3 deprivation. Together, our data demonstrate that B55alpha-dependent targeting of the PP2A holoenzyme to Akt selectively regulates Akt phosphorylation at Thr-308 to regulate cell proliferation and survival.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Consistently, an in vitro dephosphorylation assay showed that PP2A/B55α dephosphorylates AKT on Thr308 preferentially over Ser473, suggesting that B55α selectively and directly regulates AKT phosphorylation on Thr308 (Kuo et al., 2008).”
From PP2A holoenzymes, substrate specificity driving cellular functions and deregulation in cancer (2019) · cites this paper as Kuo et al., 2008
In the citing paper
“In the PI3K/AKT pathway, both PI3K and AKT downstream signaling factors are substrates of PP2A (Kuo et al., 2008; Petritsch et al., 2000).”
From PP2A holoenzymes, substrate specificity driving cellular functions and deregulation in cancer (2019) · cites this paper as Kuo et al., 2008
Citations
Cites
Phosphorylation and regulation of Akt/PKB by the rictor-mTOR complex
Sarbassov, D. D., Guertin, D. A., Ali, S. M., & Sabatini, D. M. (2005) · Science · doi:10.1126/science.1106148 · Cited by 6,216
The phosphatidylinositol 3-Kinase–AKT pathway in human cancer
Vivanco, I., & Sawyers, C. L. (2002) · Nature reviews. Cancer · doi:10.1038/nrc839 · Cited by 6,155
A System for Stable Expression of Short Interfering RNAs in Mammalian Cells
Brummelkamp, T. R., Bernards, R., & Agami, R. (2002) · Science · doi:10.1126/science.1068999 · Cited by 4,295
Cellular survival: a play in three Akts
Datta, S. R., Brunet, A., & Greenberg, M. E. (1999) · Genes & Development · doi:10.1101/gad.13.22.2905 · Cited by 4,216
Maehama, T., & Dixon, J. E. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.22.13375 · Cited by 3,104
Mechanism of activation of protein kinase B by insulin and IGF‐1.
Alessi, D. R., Andjelković, M., Caudwell, B., Cron, P. D., MORRICE, N. A., Cohen, P., & Hemmings, B. A. (1996) · The EMBO Journal · doi:10.1002/j.1460-2075.1996.tb01045.x · Cited by 3,014
Alessi, D. R., James, S. R., Downes, C. P., Holmes, A. B., Gaffney, P. R. J., Reese, C. B., & Cohen, P. (1997) · Current Biology · doi:10.1016/s0960-9822(06)00122-9 · Cited by 2,874
Exploiting the PI3K/AKT Pathway for Cancer Drug Discovery
Hennessy, B. T., Smith, D. L., Ram, P. T., Lu, Y., & Mills, G. B. (2005) · Nature Reviews Drug Discovery · doi:10.1038/nrd1902 · Cited by 2,214
Janssens, V., & Goris, J. (2001) · Biochemical Journal · doi:10.1042/0264-6021:3530417 · Cited by 1,927
The protein kinase B/Akt signalling pathway in human malignancy
Nicholson, K. M., & Anderson, N. G. (2002) · Cellular Signalling · doi:10.1016/s0898-6568(01)00271-6 · Cited by 1,665
Research works printed but not linked: 3
- Bellacosa, 1991, Science, 254, 274
- Healy, 1991, Mol. Cell. Biol., 11, 5767
- Liu, 2004, Am. J. Physiol., 286, H2204
Cited by
Sorted by citations
AKT/PKB Signaling: Navigating the Network
Manning, B. D., & Toker, A. (2017) · Cell · doi:10.1016/j.cell.2017.04.001 · Cited by 3,772
Ceramide-orchestrated signalling in cancer cells
Morad, S. A. F., & Cabot, M. C. (2012) · Nature reviews. Cancer · doi:10.1038/nrc3398 · Cited by 1,032
Protein phosphatase 2A regulatory subunits and cancer
Eichhorn, P. J. A., Creyghton, M. P., & Bernards, R. (2009) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2008.05.005 · Cited by 513
Phosphatase: PP2A structural importance, regulation and its aberrant expression in cancer
Seshacharyulu, P., Pandey, P., Datta, K., & Batra, S. K. (2013) · Cancer Letters · doi:10.1016/j.canlet.2013.02.036 · Cited by 502
PP2A as a master regulator of the cell cycle
Wlodarchak, N., & Xing, Y. (2016) · Critical Reviews in Biochemistry and Molecular Biology · doi:10.3109/10409238.2016.1143913 · Cited by 380
(2010) · PubMed Central
McCubrey, J. A., Steelman, L. S., Chappell, W. H., Abrams, S. L., Montalto, G., Cervello, M., Nicoletti, F., Fagone, P., Malaponte, G., Mazzarino, M. C., et al. (2012) · Oncotarget · doi:10.18632/oncotarget.652 · Cited by 318
Wong, Q., Ching, A. K.-K., Chan, A. W. H., Choy, K. W., To, K., Lai, P. B. S., & Wong, N. (2010) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-09-1840 · Cited by 248
Jazvinšćak Jembrek, M., Hof, P. R., & Šimić, G. (2015) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2015/346783 · Cited by 244
Abbastabar, M., Kheyrollah, M., Azizian, K., Bagherlou, N., Tehrani, S. S., Maniati, M., & Karimian, A. (2018) · DNA repair · doi:10.1016/j.dnarep.2018.07.008 · Cited by 219
Control of inflammatory responses by ceramide, sphingosine 1-phosphate and ceramide 1-phosphate
Gómez‐Muñoz, A., Presa, N., Gómez-Larrauri, A., Rivera, I.-G., Trueba, M., & Ordoñez, M. (2015) · Progress in Lipid Research · doi:10.1016/j.plipres.2015.09.002 · Cited by 220
Activation of tumor suppressor protein PP2A inhibits KRAS-driven tumor growth
Sangodkar, J., Perl, A., Tohme, R., Kiselar, J., Kastrinsky, D. B., Zaware, N., Izadmehr, S., Mazhar, S., Wiredja, D. D., O’Connor, C. M., et al. (2017) · Journal of Clinical Investigation · doi:10.1172/jci89548 · Cited by 196
Identification of Integrator-PP2A complex (INTAC), an RNA polymerase II phosphatase
Zheng, H., Qi, Y., Hu, S., Cao, X. D., Xu, C., Yin, Z., Chen, X., Li, Y., Liu, W., Li, J., et al. (2020) · Science · doi:10.1126/science.abb5872 · Cited by 196
Hales, E. C., Taub, J. W., & Matherly, L. H. (2013) · Cellular Signalling · doi:10.1016/j.cellsig.2013.09.021 · Cited by 187
Hu, Y., Jin, Y., Wu, X., Yang, Y., Li, Y., Li, H., Xiang, S., Song, X., Jiang, L., Zhang, Y., et al. (2019) · Molecular Cancer · doi:10.1186/s12943-019-1097-9 · Cited by 177
Self-citationRegulation of FOXO Factors in Mammalian Cells
Brown, A. K., & Webb, A. E. (2017) · Current topics in developmental biology/Current Topics in Developmental Biology · doi:10.1016/bs.ctdb.2017.10.006 · Cited by 177
Padmanabhan, S., Mukhopadhyay, A., Narasimhan, S. D., Tesz, G. J., Czech, M., & Tissenbaum, H. A. (2009) · Cell · doi:10.1016/j.cell.2009.01.025 · Cited by 170
Cell survival and metastasis regulation by Akt signaling in colorectal cancer
Agarwal, E., Brattain, M. G., & Chowdhury, S. (2013) · Cellular Signalling · doi:10.1016/j.cellsig.2013.03.025 · Cited by 164
REDD1 enhances protein phosphatase 2A-mediated dephosphorylation of Akt to repress mTORC1 signaling
Dennis, M. D., Coleman, C. S., Berg, A., Jefferson, L. S., & Kimball, S. R. (2014) · Science Signaling · doi:10.1126/scisignal.2005103 · Cited by 159
Ruvolo, P. P. (2016) · BBA Clinical · doi:10.1016/j.bbacli.2016.08.002 · Cited by 143
Wang, P., Zhou, Z., Hu, A., de Albuquerque, C. P., Zhou, Y., Hong, L., Sierecki, E., Ajiro, M., Kruhlak, M. J., Harris, C. C., et al. (2014) · Molecular Cell · doi:10.1016/j.molcel.2014.03.007 · Cited by 145
Szymonowicz, K., Oeck, S., Malewicz, N. M., & Jendrossek, V. (2018) · Cancers · doi:10.3390/cancers10030078 · Cited by 135
Christensen, D. J., Chen, Y., Oddo, J., Matta, K. M., Neil, J. E., Davis, E. D., Volkheimer, A. D., Lanasa, M. C., Friedman, D. R., Goodman, B. K., et al. (2011) · Blood · doi:10.1182/blood-2011-04-351072 · Cited by 133
PHLPP-1 Negatively Regulates Akt Activity and Survival in the Heart
Miyamoto, S., Purcell, N. H., Smith, J. M., Gao, T., Whittaker, R., Huang, K., Castillo, R., Glembotski, C. C., Sussman, M. A., Newton, A. C., et al. (2010) · Circulation Research · doi:10.1161/circresaha.109.215020 · Cited by 127
Self-citationAkt: a key transducer in cancer
Tsai, P., Lai, Y., Manne, R., Tsai, Y.-S., Sarbassov, D. D., & Lin, H. (2022) · Journal of Biomedical Science · doi:10.1186/s12929-022-00860-9 · Cited by 138
Christensen, D. J., Ohkubo, N., Oddo, J., Van Kanegan, M. J., Neil, J., Li, F., Colton, C. A., & Vitek, M. P. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1002847 · Cited by 125
Uko, N. E., Güner, O. F., Matesic, D. F., & Bowen, J. P. (2020) · Current Topics in Medicinal Chemistry · doi:10.2174/1568026620666200224101808 · Cited by 125
Martelli, A. M., Chiarini, F., Evangelisti, C., Cappellini, A., Buontempo, F., Bressanin, D., Fini, M., & McCubrey, J. A. (2012) · Oncotarget · doi:10.18632/oncotarget.477 · Cited by 122
Tumor Microenvironment Metabolism: A New Checkpoint for Anti-Tumor Immunity
Scharping, N. E., & Delgoffe, G. M. (2016) · Vaccines · doi:10.3390/vaccines4040046 · Cited by 120
Tan, J. Y., Lee, P. L., Li, Z., Jiang, X., Lim, Y. C., Hooi, S. C., & Yu, Q. (2010) · Cancer Cell · doi:10.1016/j.ccr.2010.10.021 · Cited by 119
Intrapericardial Exosome Therapy Dampens Cardiac Injury via Activating Foxo3
Zhu, D., Liu, S., Huang, K., Wang, Z., Hu, S., Li, J., Li, Z., & Cheng, K. (2022) · Circulation Research · doi:10.1161/circresaha.122.321384 · Cited by 119
Self-citationThe role of PI3K/Akt in human herpesvirus infection: From the bench to the bedside
Liu, X., & Cohen, J. I. (2015) · Virology · doi:10.1016/j.virol.2015.02.040 · Cited by 117
Targeting Inhibitors of the Tumor Suppressor PP2A for the Treatment of Pancreatic Cancer
Farrell, A. S., Allen-Petersen, B., Daniel, C. J., Wang, X., Wang, Z., Rodriguez, S., Impey, S., Oddo, J., Vitek, M. P., Lopez, C., et al. (2014) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-13-0542 · Cited by 114
Anesthesia Induces Phosphorylation of Tau
Run, X., Liang, Z., Zhang, L., Iqbal, K., Grundke, I., & Gong, C. (2009) · Journal of Alzheimer s Disease · doi:10.3233/jad-2009-1003 · Cited by 112
Reddy, C. A., Venkateswarlu, S., Golakoti, T., Kanugula, A. K., Karnewar, S., Karthikraj, R., Nagarjuna, V., Prabhakar, S., Kuppusamy, P., Kotamraju, S., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0089351 · Cited by 108
Zhang, Y., Talmon, G., & Wang, J. (2015) · Cell Death & Disease · doi:10.1038/cddis.2015.200 · Cited by 104
USP49 negatively regulates tumorigenesis and chemoresistance through FKBP51‐AKT signaling
Luo, K., Li, Y., Yin, Y., Li, L., Wu, C., Chen, Y., Nowsheen, S., Hu, Q., Zhang, L., Lou, Z., et al. (2017) · The EMBO Journal · doi:10.15252/embj.201695669 · Cited by 104
Carnagarin, R., Dharmarajan, A., & Dass, C. R. (2015) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2015.09.004 · Cited by 110
Xiao, L., Gong, L., Yuan, D., Deng, M., Zeng, X.-M., Chen, L.-L., Zhang, L., Yan, Q., Liu, J.-P., Hu, X.-H., et al. (2010) · Cell Death and Differentiation · doi:10.1038/cdd.2010.16 · Cited by 97
Meeusen, B., & Janssens, V. (2018) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2017.10.002 · Cited by 96
Liu, H., Gu, Y., Wang, H., Yin, J., Zheng, G., Zhang, Z., Lu, M., Wang, C., & He, Z. (2015) · Oncotarget · doi:10.18632/oncotarget.3818 · Cited by 96
PP2A holoenzymes, substrate specificity driving cellular functions and deregulation in cancer
(2019) · Advances in Cancer Research · doi:10.1016/bs.acr.2019.03.009 · Cited by 93
Janssens, V., & Rebollo, A. (2012) · Current Molecular Medicine · doi:10.2174/156652412799218930 · Cited by 95
Brito, V., Puigdellívol, M., Giralt, A., del Toro, D., Alberch, J., & Ginés, S. (2013) · Cell Death and Disease · doi:10.1038/cddis.2013.116 · Cited by 95
Ruvolo, P. P., Qui, Y. H., Coombes, K. R., Zhang, N., Ruvolo, V. R., Borthakur, G. M., Konopleva, M. Y., Andreeff, M., & Kornblau, S. M. (2011) · Leukemia · doi:10.1038/leu.2011.146 · Cited by 89
Phadngam, S., Castiglioni, A., Ferraresi, A., Morani, F., Follo, C., & Isidoro, C. (2016) · Oncotarget · doi:10.18632/oncotarget.13113 · Cited by 86
Resistance of Akt kinases to dephosphorylation through ATP-dependent conformational plasticity
Chan, T. O., Zhang, J., Rodeck, U., Pascal, J. M., Armen, R. S., Spring, M., Dumitru, C. D., Myers, V. D., Li, X., Cheung, J. Y., et al. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1109879108 · Cited by 86
RhoB loss induces Rac1-dependent mesenchymal cell invasion in lung cells through PP2A inhibition
Bousquet, E., Calvayrac, O., Mazières, J., Lajoie‐Mazenc, I., Boubekeur, N., Favre, G., & Pradines, A. (2015) · Oncogene · doi:10.1038/onc.2015.240 · Cited by 85
Kaur, M., & Cole, M. D. (2012) · Cancer Research · doi:10.1158/0008-5472.can-12-2522 · Cited by 84
AKT Regulates NLRP3 Inflammasome Activation by Phosphorylating NLRP3 Serine 5
Zhao, W., Shi, C.-S., Harrison, K., Hwang, I., Nabar, N. R., Wang, M., & Kehrl, J. H. (2020) · The Journal of Immunology · doi:10.4049/jimmunol.2000649 · Cited by 89
Brewer, C. M., Nelson, B. R., Wakenight, P., Collins, S., Okamura, D. M., Dong, X. R., Mahoney, W. M., McKenna, A., Shendure, J., Timms, A. E., et al. (2021) · Developmental Cell · doi:10.1016/j.devcel.2021.09.008 · Cited by 83
Sierecki, E., Sinko, W., McCammon, J. A., & Newton, A. C. (2010) · Journal of Medicinal Chemistry · doi:10.1021/jm100331d · Cited by 82
Yuan, D., Zhou, S., Liu, S., Li, K., Zhao, H., Long, S., Liu, H., Xie, Y., Su, Y., Yu, F., et al. (2020) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2000963117 · Cited by 81
PP2A: The Wolf in Sheep’s Clothing?
Bailey‐Whyte, M., & Kiely, P. (2015) · Cancers · doi:10.3390/cancers7020648 · Cited by 82
Shen, S., Yue, H., Li, Y., Qin, J., Li, K., Liu, Y., & Wang, J. (2013) · Tumor Biology · doi:10.1007/s13277-013-1087-2 · Cited by 77
Sobral, L. M., Sousa, L. O., Coletta, R. D., Cabral, H., Greene, L. J., Tajara, E. H., Gutkind, J. S., Curti, C., & Leopoldino, A. M. (2014) · Molecular Cancer · doi:10.1186/1476-4598-13-32 · Cited by 76
Han, X., Li, B., Ye, X., Mulatibieke, T., Wu, J., Dai, J., Wu, D., Ni, J., Zhang, R., Xue, J., et al. (2017) · British Journal of Pharmacology · doi:10.1111/bph.14057 · Cited by 79
Protein phosphatase 2A – structure, function and role in neurodevelopmental disorders
Sandal, P., Jong, C. J., Merrill, R. A., Song, J., & Strack, S. (2021) · Journal of Cell Science · doi:10.1242/jcs.248187 · Cited by 76
He, X., Li, M., Yu, H., Liu, G., Wang, N., Yin, C., Tu, Q., Narla, G., Tao, Y., Cheng, S., et al. (2020) · PLoS Biology · doi:10.1371/journal.pbio.3000803 · Cited by 76
In vitro and in vivo anti-inflammatory effects of ethanol extract from Acer tegmentosum
Yu, T., Lee, J., Lee, Y. G., Byeon, S. E., Kim, M. H., Sohn, E., Lee, Y. J., Lee, S. G., & Cho, J. Y. (2010) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2009.12.042 · Cited by 75
Phua, W. W. T., Wong, M. X. Y., Liao, Z., & Tan, N. S. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19051425 · Cited by 72
Wei, C., Zhu, M.-X., Lu, N., Peng, R., Yang, X., Zhang, P.-F., Wang, L., & Gu, J. (2018) · Oncogene · doi:10.1038/s41388-018-0531-6 · Cited by 72
Reengineered tricyclic anti-cancer agents
Kastrinsky, D. B., Sangodkar, J., Zaware, N., Izadmehr, S., Dhawan, N. S., Narla, G., & Ohlmeyer, M. H. J. (2015) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2015.07.007 · Cited by 71
Yu, T., Lee, S., Yang, W. S., Jang, H., Lee, Y. J., Kim, T., Kim, S. Y., Lee, J., & Cho, J. Y. (2011) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2011.11.051 · Cited by 70
Ceramide Acyl Chain Length and Its Relevance to Intracellular Lipid Regulation
Ho, Q. W. C., Zheng, X., & Ali, Y. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23179697 · Cited by 68
AKT signaling in ERBB2-amplified breast cancer
Carmona, F. J., Montemurro, F., Kannan, S., Rossi, V., Verma, C. S., Baselga, J. M., & Scaltriti, M. (2015) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2015.11.013 · Cited by 70
Heparanase, cell signaling, and viral infections
Koganti, R., Suryawanshi, R., & Shukla, D. (2020) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-020-03559-y · Cited by 67
Naetar, N., Soundarapandian, V., Litovchick, L., Goguen, K. L., Sablina, A. A., Bowman-Colin, C., Siciński, P., Hahn, W. C., DeCaprio, J. A., & Livingston, D. M. (2014) · Molecular Cell · doi:10.1016/j.molcel.2014.04.023 · Cited by 67
Rizvi, F., Shukla, S., & Kakkar, P. (2014) · Cell Death and Disease · doi:10.1038/cddis.2014.118 · Cited by 67
Protein Phosphatase 2A as a Therapeutic Target in Acute Myeloid Leukemia
Arriazu, E., Pippa, R., & Odero, M. D. (2016) · Frontiers in Oncology · doi:10.3389/fonc.2016.00078 · Cited by 66
Hein, A. L., Seshacharyulu, P., Rachagani, S., Sheinin, Y. M., Ouellette, M. M., Ponnusamy, M. P., Mumby, M. C., Batra, S. K., & Yan, Y. (2016) · Cancer Research · doi:10.1158/0008-5472.can-15-2119 · Cited by 66
AMBRA1 Controls Regulatory T-Cell Differentiation and Homeostasis Upstream of the FOXO3-FOXP3 Axis
Becher, J., Simula, L., Volpe, E., Procaccini, C., Rocca, C. L., D’Acunzo, P., Cianfanelli, V., Strappazzon, F., Caruana, I., Nazio, F., et al. (2018) · Developmental Cell · doi:10.1016/j.devcel.2018.11.010 · Cited by 66
GAPDH binds to active Akt, leading to Bcl-xL increase and escape from caspase-independent cell death
Jacquin, M. A., Chiche, J., Zunino, B., Bénéteau, M., Meynet, O., La, P., Marchetti, S., Cornille, A., Carlès, M., & Ricci, J. (2013) · Cell Death and Differentiation · doi:10.1038/cdd.2013.32 · Cited by 66
Restricted Protein Phosphatase 2A Targeting by Merkel Cell Polyomavirus Small T Antigen
Kwun, H. J., Shuda, M., Camacho, C. J., Gamper, A. M., Thant, M., Chang, Y., & Moore, P. S. (2015) · Journal of Virology · doi:10.1128/jvi.00157-15 · Cited by 66
Cheng, Y., Liu, W., Kim, S.-T., Sun, J., Lu, L., Sun, J., Zheng, S. L., Isaacs, W. B., & Xu, J. (2011) · Cancer Genetics · doi:10.1016/j.cancergen.2011.05.002 · Cited by 64
Meng, G., Wang, W., Chai, K., YANG, S., Li, F., & JIANG, K. (2015) · International Journal of Oncology · doi:10.3892/ijo.2015.2814 · Cited by 62
Wandzioch, E., Pusey, M., Werda, A., Bail, S., Bhaskar, A., Nestor, M., Yang, J., & Rice, L. M. (2014) · Cancer Research · doi:10.1158/0008-5472.can-13-3130 · Cited by 64
KIBRA Protein Phosphorylation Is Regulated by Mitotic Kinase Aurora and Protein Phosphatase 1
Xiao, L., Chen, Y., Ji, M. H., Volle, D. J., Lewis, R. E., Tsai, M.-Y., & Dong, J. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.246850 · Cited by 62
Downregulation of MicroRNA miR-520h by E1A Contributes to Anticancer Activity
Su, J.-L., Chen, P. B., Chen, Y.-H., Chen, S., Chang, Y.-W., Jan, Y., Cheng, X., Hsiao, M., & Hung, M. (2010) · Cancer Research · doi:10.1158/0008-5472.can-09-4148 · Cited by 60
Jackson, J. B., & Pallas, D. C. (2012) · Neoplasia · doi:10.1593/neo.12768 · Cited by 60
Greatwall promotes cell transformation by hyperactivating AKT in human malignancies
Vera, J., Lartigue, L., Vigneron, S., Gadéa, G., Gire, V., Rio, M. D., Soubeyran, I., Chibon, F., Lorca, T., & Castro, A. (2015) · eLife · doi:10.7554/elife.10115 · Cited by 60
Wang, L., Ouyang, F., Liu, X., Wu, S., Wu, H., Xu, Y., Wang, B., Zhu, J., Xu, X., & Zhang, L. (2015) · Oncotarget · doi:10.18632/oncotarget.6302 · Cited by 58
Roth, S. W., Bitterman, M. D., Birnbaum, M. J., & Bland, M. L. (2018) · Cell Reports · doi:10.1016/j.celrep.2018.02.033 · Cited by 58
EZH2-mediated PP2A inactivation confers resistance to HER2-targeted breast cancer therapy
Bao, Y., Oguz, G., Lee, W. C., Lee, P. L., Ghosh, K., Li, J., Wang, P., Lobie, P. E., Ehmsen, S., Ditzel, H. J., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-19704-x · Cited by 58
Self-citationLeopoldino, A. M., SQUARIZE, C. H., Garcia, C. B., Almeida, L. O., Pestana, C. R., Sobral, L. M., Uyemura, S. A., Tajara, E. H., Gutkind, J. S., & Curti, C. (2012) · Oral Oncology · doi:10.1016/j.oraloncology.2012.05.014 · Cited by 56
Galbo, T., Olsen, G. S., Quistorff, B., & Nishimura, E. (2011) · PLoS ONE · doi:10.1371/journal.pone.0027424 · Cited by 60
Nelson, V. L., Jiang, Y., Dickman, K. G., Ballou, L. M., & Lin, R. Z. (2014) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00625.2013 · Cited by 55
A Novel Epac-Rap-PP2A Signaling Module Controls cAMP-dependent Akt Regulation
Hong, K., Lou, L., Gupta, S., Ribeiro-Neto, F., & Altschuler, D. L. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m800478200 · Cited by 56
Ruffini, F., D’Atri, S., & Lacal, P. M. (2013) · International Journal of Oncology · doi:10.3892/ijo.2013.1948 · Cited by 55
STRIPAK directs PP2A activity toward MAP4K4 to promote oncogenic transformation of human cells
Kim, J. W., Berrios, C. J., Kim, M., Schade, A. E., Adelmant, G., Yeerna, H., Damato, E., Iniguez, A. B., Swanson, S. K., Florens, L. A., et al. (2020) · eLife · doi:10.7554/elife.53003 · Cited by 54
PHLPP1 Gene Deletion Protects the Brain from Ischemic Injury
Chen, B., Winkle, J. A. V., Lyden, P. D., Brown, J. H., & Purcell, N. H. (2012) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/jcbfm.2012.150 · Cited by 54
Growth hormone modulation of EGF-induced PI3K-Akt pathway in mice liver
Díaz, M. E., González, L., Miquet, J. G., Martinez, C. S., Sotelo, A. I., Bartke, A., & Turyn, D. (2011) · Cellular Signalling · doi:10.1016/j.cellsig.2011.10.001 · Cited by 54
Raman, D., & Pervaiz, S. (2019) · Redox Biology · doi:10.1016/j.redox.2019.101105 · Cited by 58
MIG-7 Controls COX-2/PGE2-Mediated Lung Cancer Metastasis
Ho, M., Liang, S., Hung, S., & Liang, C. (2012) · Cancer Research · doi:10.1158/0008-5472.can-12-2220 · Cited by 53
RetractedLong noncoding RNA GMAN promotes hepatocellular carcinoma progression by interacting with eIF4B
Xu, J., Lu, Y., Liu, Q., Xia, A., Zhao, J., Xu, X., Sun, Q., Qi, F., & Sun, B. (2019) · Cancer Letters · doi:10.1016/j.canlet.2019.12.032 · Cited by 51
Zou, Q., Xiao, X., Liang, Y. J., Peng, L., Guo, Z., Li, W., & Yu, W. (2018) · Cancer Letters · doi:10.1016/j.canlet.2018.04.027 · Cited by 47
InterAKTions with FKBPs - Mutational and Pharmacological Exploration
Fabian, A., März, A., Neimanis, S., Biondi, R. M., Kozany, C., & Hausch, F. (2013) · PLoS ONE · doi:10.1371/journal.pone.0057508 · Cited by 51
Hsin, I., Shen, H., Chang, H. H., Ko, J., & Wang, P.-H. (2021) · Cells · doi:10.3390/cells10112916 · Cited by 50
Aspirin sensitivity of PIK3CA-mutated Colorectal Cancer: potential mechanisms revisited
Hall, D. C. N., & Benndorf, R. A. (2022) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-022-04430-y · Cited by 48
Chung, Y. W., Kim, H.-K., Kim, I. Y., Yim, M. B., & Chock, P. B. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.264945 · Cited by 47
Metadata
- Authors
- Kuo, Y.-C., Huang, K.-Y., Yang, C.-H., Yang, Y.-S., Lee, W.-Y., & Chiang, C.-W.
- Affiliations
- National Cheng Kung University (TW)
- Corresponding author
- Chiang, Chi-Wu
- Venue
- Journal of Biological Chemistry
- Publisher
- Elsevier BV
- Published
- 2008-01
- Volume
- 283
- Issue
- 4
- Pages
- 1882-1892
- ISSN
- 0021-9258 (ISSN-L)
- OpenAlex
- W2045852899
- Cited by
- 367
- References
- 72
- Citations by year
- 2026: 12 · 2025: 18 · 2024: 14 · 2023: 15 · 2022: 23 · 2021: 22 · 2020: 27 · 2019: 20 · 2018: 25 · 2017: 30 · 2016: 20 · 2015: 32 · 2014: 26 · 2013: 18 · 2012: 17
- FWCI
- 4.24
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Journal of Biological Chemistry (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › PI3K/AKT/mTOR signaling in cancer
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Kinase Regulation and GTPase Signaling
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Signaling Pathways in Disease
- Keywords
- Akt, protein phosphatase 2A, PP2A holoenzyme, Akt dephosphorylation, FOXO3, cell proliferation, cell survival, NIH3T3 cells
- MeSH terms
- Animals, Cell Survival, Humans, Interleukin-3, Phosphorylation, Holoenzymes, Gene Silencing, NIH 3T3 Cells, Cell Proliferation, Proto-Oncogene Proteins c-akt, Mice, Protein Phosphatase 2
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review